A Multicenter Observational Study of Treatment and Outcomes in Chinese Adults with Chronic Kidney Disease

What this Trial Is About

Researchers are conducting a prospective, multicenter, observational registry study to better understand treatments, clinical practices, and heart and kidney-related health outcomes in Chinese adults with chronic kidney disease CKD. The study will include about 3000 participants from around 80 hospitals across various regions in China, representing different levels of medical care. The goal is to reflect real-world clinical practice and observe differences in treatment approaches among this population. Participants will be enrolled after providing written informed consent. Data will be collected from their medical records and entered into a secure electronic system designed to ensure quality and accurate data capture. The study will follow participants for up to 96 weeks, collecting information on medication use, clinical indicators, and health outcomes related to CKD and associated conditions such as hypertension, heart failure, and hyperkalemia. During the study, researchers will gather data at regular intervals from medical records without administering any treatments or interventions. They will assess the proportion of patients with certain complications, medication adoption rates, and clinical outcomes over the 96-week period. This long-term follow-up will help deepen understanding of CKD management and related risks. Participants will not be required to attend extra visits beyond routine care for data collection.

A Prospecitve Multicenter, Observational Registry Study